• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病(COPD)的药物治疗管理。基于真实世界证据的研究 - 第 2 部分。

Pharmacological Management of Chronic Obstructive Lung Disease (COPD). Evidence from a Real-World Perspective - Part 2.

机构信息

Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Pisana, Via di Valcannuta, 247, I-00166 Rome, Italy.

Unit of Pulmonary Rehabilitation, IRCCS San Raffaele Pisana, Via della Pisana, 235, 00163 Rome, Italy.

出版信息

Curr Med Chem. 2019;26(10):1734-1745. doi: 10.2174/0929867325666181031101128.

DOI:10.2174/0929867325666181031101128
PMID:30378484
Abstract

BACKGROUND

We report a comprehensive overview of current COPD therapies from a real-world experience.

OBJECTIVE

Critically review the opportunities and the challenges occurring in the real-world treatment of COPD.

METHODS

This is a review that also report results from COPD patients treated with standardized therapy including pulmonary rehabilitation (Real World Data - RWD).

CONCLUSION

Comprehensive assessment of COPD management requires strategies able to evaluate efficacy and usefulness in a real-world population, that take into account the interaction between experience and academic training, research, adherence to guidelines and judgments in order to plan the appropriate and optimum use of available strategies.

摘要

背景

我们从实际经验报告了当前 COPD 治疗的综合概述。

目的

从实际治疗 COPD 的角度,严格审查现有的机遇和挑战。

方法

这是一篇综述,还报告了接受标准化治疗(包括肺康复)的 COPD 患者的结果。

结论

全面评估 COPD 管理需要能够评估真实人群中疗效和有用性的策略,这些策略需要考虑经验与学术培训、研究、对指南的依从性和判断之间的相互作用,以便为现有策略的合理和优化使用做好计划。

相似文献

1
Pharmacological Management of Chronic Obstructive Lung Disease (COPD). Evidence from a Real-World Perspective - Part 2.慢性阻塞性肺疾病(COPD)的药物治疗管理。基于真实世界证据的研究 - 第 2 部分。
Curr Med Chem. 2019;26(10):1734-1745. doi: 10.2174/0929867325666181031101128.
2
Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.慢性阻塞性肺疾病 - 稳定期疾病的诊断和管理;基于临床表型的可治疗特征概念,采用个体化护理方法。捷克肺病和结核学会立场文件。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Dec;164(4):325-356. doi: 10.5507/bp.2020.056.
3
Pharmacological Management of Chronic Obstructive Lung Disease (COPD). Focus on Mutations - Part 1.慢性阻塞性肺疾病(COPD)的药物治疗。聚焦于突变——第 1 部分。
Curr Med Chem. 2019;26(10):1721-1733. doi: 10.2174/0929867325666180601100235.
4
Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis.真实世界中慢性阻塞性肺疾病初诊患者的治疗:一项德国回顾性索赔数据分析。
Int J Chron Obstruct Pulmon Dis. 2022 Sep 22;17:2355-2367. doi: 10.2147/COPD.S375190. eCollection 2022.
5
Hospitalised exacerbations of chronic obstructive pulmonary disease: adherence to guideline recommendations in an Australian teaching hospital.慢性阻塞性肺疾病住院加重期:澳大利亚教学医院对指南推荐的遵循情况。
Intern Med J. 2020 Apr;50(4):453-459. doi: 10.1111/imj.14378.
6
Active mind-body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease.主动身心运动疗法作为慢性阻塞性肺疾病患者肺康复的辅助疗法或与之对比的疗法。
Cochrane Database Syst Rev. 2018 Oct 10;10(10):CD012290. doi: 10.1002/14651858.CD012290.pub2.
7
Diagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinic.在基层医疗机构中对慢性阻塞性肺疾病(COPD)进行诊断和管理。
COPD. 2009 Dec;6(6):446-51. doi: 10.3109/15412550903341455.
8
Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany.德国肺病专家基于指南对门诊 COPD 管理的调查。
Int J Chron Obstruct Pulmon Dis. 2012;7:101-8. doi: 10.2147/COPD.S27887. Epub 2012 Feb 14.
9
The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study.2011年和2017年慢性阻塞性肺疾病全球倡议(GOLD)指南对台湾慢性阻塞性肺疾病患者分配及药物治疗的影响:台湾阻塞性肺病(TOLD)研究
Int J Chron Obstruct Pulmon Dis. 2018 Sep 25;13:2949-2959. doi: 10.2147/COPD.S176065. eCollection 2018.
10
Guideline for the management of chronic obstructive pulmonary disease--2011 update.慢性阻塞性肺疾病管理指南——2011 年更新版。
S Afr Med J. 2011 Jan;101(1 Pt 2):63-73.

引用本文的文献

1
Therapeutic Targeting of MMP-12 for the Treatment of Chronic Obstructive Pulmonary Disease.基质金属蛋白酶-12 的治疗靶点在慢性阻塞性肺疾病治疗中的作用
J Med Chem. 2020 Nov 12;63(21):12911-12920. doi: 10.1021/acs.jmedchem.0c01285. Epub 2020 Oct 27.
2
Metabolic Disorder in Chronic Obstructive Pulmonary Disease (COPD) Patients: Towards a Personalized Approach Using Marine Drug Derivatives.慢性阻塞性肺疾病(COPD)患者的代谢紊乱:迈向使用海洋药物衍生物的个性化治疗方法。
Mar Drugs. 2017 Mar 20;15(3):81. doi: 10.3390/md15030081.